ArticleEuropean urology open science2023

Management of Fibroblast Growth Factor Inhibitor Treatment-emergent Adverse Events of Interest in Patients with Locally Advanced or Metastatic Urothelial Carcinoma.

Arlene O Siefker-Radtke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.